The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Regulation of SMN Protein Stability
Open accessAbstract
Spinal muscular atrophy (SMA) is caused by mutations of the survival of motor neuron (SMN1) gene and deficiency of full-length SMN protein (FL-SMN). All SMA patients retain one or more copies of the SMN2 gene, but the principal protein product of SMN2 lacks exon 7 (SMNDelta7) and is unable to compensate for a deficiency of FL-SMN. SMN is known to oligomerize and form a multimeric protein complex; however, the mechanisms regulating stability and degradation of FL-SMN and SMNDelta7 proteins have been largely unexplored. Using pulse-chase analysis, we characterized SMN protein turnover and confirmed that SMN was ubiquitinated and degraded by the ubiquitin proteasome system (UPS). The SMNDelta7 protein had a twofold shorter half-life than FL-SMN in cells despite similar intrinsic rates of turnover by the UPS in a cell-free assay. Mutations that inhibited SMN oligomerization and complex formation reduced the FL-SMN half-life. Furthermore, recruitment of SMN into large macromolecular complexes as well as increased association with several Gemin proteins was regulated in part by protein kinase A. Together, our data indicate that SMN protein stability is modulated by complex formation. Promotion of the SMN complex formation may be an important novel therapeutic strategy for SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Majumder, S., Varadharaj, S., Ghoshal, K., Monani, U. R., Burghes, A. H. M., & Jacob, S. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308225200 · Cited by 57
RetractedIdentification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Sequence and structure-based prediction of eukaryotic protein phosphorylation sites
Blom, N., Gammeltoft, S., & Brunak, S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3310 · Cited by 3,188
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Correlation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
A novel nuclear structure containing the survival of motor neurons protein.
Liu, Q., & Dreyfuss, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00725.x · Cited by 780
A mouse model for spinal muscular atrophy
Hsieh-Li, H. M., Chang, J.-G., Jong, Y.-J., Wu, M.-H., Wang, N. M., Tsai, C. H., & Li, H. (2000) · Nature Genetics · doi:10.1038/71709 · Cited by 702
Liu, Q., Fischer, U., Wang, F., & Dreyfuss, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80367-0 · Cited by 657
Zhang, Z., Lotti, F., Dittmar, K., Younis, I., Wan, L., Kasim, M., & Dreyfuss, G. (2008) · Cell · doi:10.1016/j.cell.2008.03.031 · Cited by 617
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Essential Role for the SMN Complex in the Specificity of snRNP Assembly
Pellizzoni, L., Yong, J., & Dreyfuss, G. (2002) · Science · doi:10.1126/science.1074962 · Cited by 545
SMN oligomerization defect correlates with spinal muscular atrophy severity
Lorson, C. L., Strasswimmer, J., Yao, J.-M., Baleja, J. D., Hahnen, E., Wirth, B., Le, T., Burghes, A. H. M., & Androphy, E. J. (1998) · Nature Genetics · doi:10.1038/ng0598-63 · Cited by 500
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
Lorson, C. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.259 · Cited by 435
The SMN complex, an assemblyosome of ribonucleoproteins
Paushkin, S., Gubitz, A. K., Massenet, S., & Dreyfuss, G. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00332-0 · Cited by 351
Gabanella, F., Butchbach, M. E. R., Saieva, L., Carissimi, C., Burghes, A. H. M., & Pellizzoni, L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000921 · Cited by 315
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
Sumner, C. J., Huynh, T. N., Markowitz, J. A., Perhac, J. S., Hill, B., Coovert, D. D., Schussler, K., Chen, X., Jarecki, J., Burghes, A. H. M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10743 · Cited by 289
Self-citationCharroux, B., Pellizzoni, L., Perkinson, R. A., Shevchenko, A., Mann, M., & Dreyfuss, G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.6.1181 · Cited by 274
SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins
Pellizzoni, L., Charroux, B., & Dreyfuss, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11167 · Cited by 246
Salbutamol, a β 2-adrenoceptor agonist, increases skeletal muscle strength in young men
Martineau, L., Horan, M. A., Rothwell, N. J., & Little, R. A. (1992) · Clinical Science · doi:10.1042/cs0830615 · Cited by 231
Zhang, H., Xing, L., Rossoll, W., Wichterle, H., Singer, R. H., & Bassell, G. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3967-05.2006 · Cited by 200
Jablonka, S., Beck, M., Lechner, B. D., Mayer, C., & Sendtner, M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703187 · Cited by 172
Gemin5, a Novel WD Repeat Protein Component of the SMN Complex That Binds Sm Proteins
Gubitz, A. K., Mourelatos, Z., Abel, L., Rappsilber, J., Mann, M., & Dreyfuss, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109448200 · Cited by 169
Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2
Prior, T. W., Swoboda, K. J., Scott, H. D., & Hejmanowski, A. Q. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30251 · Cited by 164
The role of histone acetylation in SMN gene expression
Kernochan, L. E., Russo, M. L., Woodling, N. S., Huynh, T. N., Avila, A. M., Fischbeck, K. H., & Sumner, C. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi130 · Cited by 164
Self-citation?2-Adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium
Kaumann, A. J., & Lemoine, H. (1987) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165555 · Cited by 163
A Comprehensive Interaction Map of the Human Survival of Motor Neuron (SMN) Complex
Otter, S., Grimmler, M., Neuenkirchen, N., Chari, A., Sickmann, A., & Fischer, U. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608528200 · Cited by 154
Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity
Palazzolo, I., Burnett, B. G., Young, J. E., Brenne, P. L., Spada, A. R. L., Fischbeck, K. H., Howell, B. W., & Pennuto, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm109 · Cited by 150
Self-citationBaccon, J., Pellizzoni, L., Rappsilber, J., Mann, M., & Dreyfuss, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203478200 · Cited by 135
Pilot trial of albuterol in spinal muscular atrophy
Kinali, M., Mercuri, E. M., Main, M. L., Biasia, F. D., Karatza, A., Higgins, R., Banks, L. M., Manzur, A. Y., & Muntoni, F. (2002) · Neurology · doi:10.1212/wnl.59.4.609 · Cited by 132
Clenbuterol, a β-Adrenoceptor Agonist, Increases Relative Muscle Strength in Orthopaedic Patients
Maltin, C. A., Delday, M. I., Watson, J. S., Heys, S. D., Nevison, I. M., Ritchie, I. K., & Gibson, P. H. (1993) · Clinical Science · doi:10.1042/cs0840651 · Cited by 126
Refined Characterization of the Expression and Stability of the SMN Gene Products
Vitte, J., Fassier, C., Tiziano, F. D., Dalard, C., Soave, S., Roblot, N., Brahe, C., Saugier-Véber, P., Bonnefont, J., & Melki, J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070399 · Cited by 112
SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain
Walker, M. P., Rajendra, T. K., Saieva, L., Fuentes, J. L., Pellizzoni, L., & Matera, A. G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn234 · Cited by 99
Young, P. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2869 · Cited by 97
Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells
Angelozzi, C., Borgo, F., Tiziano, F. D., Martella, A., Neri, G., & Brahe, C. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051177 · Cited by 91
Degradation of survival motor neuron (SMN) protein is mediated via the ubiquitin/proteasome pathway
Chang, H., Hung, W., Chuang, Y.-J., & Jong, Y. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.04.005 · Cited by 88
Inactivation of the SMN Complex by Oxidative Stress
Wan, L., Ottinger, E. A., Cho, S., & Dreyfuss, G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.004 · Cited by 81
Phosphorylation regulates the activity of the SMN complex during assembly of spliceosomal U snRNPs
Grimmler, M., Bauer, L., Nousiainen, M., et al. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400301 · Cited by 70
A novel cell immunoassay to measure survival of motor neurons protein in blood cells
Kolb, S. J., Gubitz, A. K., Olszewski, R. F., Ottinger, E. A., Sumner, C. J., Fischbeck, K. H., & Dreyfuss, G. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-6 · Cited by 33
Self-citationMolecular targeting of E3 ligases – a therapeutic approach for cancer
Lakshmanan, M., Bughani, U., Duraisamy, S., Diwan, M., Dastidar, S. G., & Ray, A. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.855 · Cited by 23
Clenbuterol mimics effects of innervation on myogenic regulatory factor expression
Maltin, C. A., Delday, M. I., Campbell, G. P., & Hesketh, J. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.1.e176 · Cited by 18
Cited by
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Burghes, A. H. M., & Beattie, C. E. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2670 · Cited by 723
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Naryshkin, N. A., Weetall, M., Dakka, A., Narasimhan, J., Zhao, X., Feng, Z., Ling, K. K. Y., Karp, G. M., Qi, H., Woll, M. G., et al. (2014) · Science · doi:10.1126/science.1250127 · Cited by 524
SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice
Palacino, J., Swalley, S. E., Song, C., Cheung, A. K., Shu, L., Zhang, X., Van Hoosear, M., Shin, Y., Chin, D. N., Keller, C. G., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1837 · Cited by 432
Spinal muscular atrophy: Diagnosis and management in a new therapeutic era
Arnold, W. D., Kassar, D., & Kissel, J. T. (2015) · Muscle & Nerve · doi:10.1002/mus.24497 · Cited by 436
Mercuri, E., Sumner, C. J., Muntoni, F., Darras, B. T., & Finkel, R. S. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00380-8 · Cited by 430
Self-citation
Metadata
- Authors
- Burnett, B. G., Muñoz, E., Tandon, A., Kwon, D. Y., Sumner, C. J., & Fischbeck, K. H.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-03-01
- Volume
- 29
- Issue
- 5
- Pages
- 1107-1115
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2167590477
- Cited by
- 281
- References
- 42
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.